Literature DB >> 25887085

An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.

Ying Xian Chua1, Li Wei Ang2, Constance Low3, Lyn James2, Jeffery L Cutter3, Kee Tai Goh4.   

Abstract

OBJECTIVE: In line with regional and global goals for the elimination of rubella and congenital rubella syndrome (CRS), we reviewed the epidemiological situation in Singapore, based on surveillance reports on rubella and CRS, national immunization coverage and seroprevalence surveys. The aim of our review was to identify current gaps and steps taken to achieve the targets set by the World Health Organization (WHO) Western Pacific Regional Office (WPRO).
METHODS: Epidemiological data on clinical and laboratory-confirmed rubella cases, including CRS, notified to the Communicable Diseases Division, Ministry of Health, Singapore, from 2003 to 2013 were collated and analyzed. Vaccination coverage against rubella was obtained from the National Immunization Registry and School Health Services of the Health Promotion Board. The changing prevalence of rubella was determined from periodic serological surveys.
FINDINGS: The incidence of indigenous rubella cases per million population decreased from 37.2 in 2008 to 7.6 in 2013 and there had been no indigenous case of CRS in 2012 and 2013. Therapeutic abortions performed due to rubella infections had become uncommon. The annual measles, mumps, and rubella (MMR) vaccination coverage in childhood population remained high ranging from 93% to 96%. The overall susceptibility to rubella in women aged 18-44 years had reduced significantly from 15.8% in 2004 to 11.0% in 2010. The prevalence of IgG antibody against rubella among Singapore children aged 1-17 years was maintained at 87.3% in 2008-2010.
CONCLUSION: All available data indicated that Singapore has made good progress towards the elimination of rubella and CRS. It has attained the targets set by the WHO WPRO for 2015. In preparation for verification of rubella elimination, an enhanced surveillance system has been implemented to ensure that all reported cases are laboratory confirmed, and genotyping of rubella virus strains isolated is carried out to provide evidence for interruption of endemic transmission.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Epidemiology; Seroprevalence; Surveillance; Therapeutic abortion; Vaccination

Mesh:

Substances:

Year:  2015        PMID: 25887085     DOI: 10.1016/j.vaccine.2015.04.003

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses.

Authors:  Masaya M Saito; Keisuke Ejima; Ryo Kinoshita; Hiroshi Nishiura
Journal:  Int J Environ Res Public Health       Date:  2018-03-22       Impact factor: 3.390

2.  Evaluation of the trends in the incidence of infectious diseases using the syndromic surveillance system, early warning and response unit, Mongolia, from 2009 to 2017: a retrospective descriptive multi-year analytical study.

Authors:  Badral Davgasuren; Suvdmaa Nyam; Tsoggerel Altangerel; Oyunbileg Ishdorj; Ambaselmaa Amarjargal; Jun Yong Choi
Journal:  BMC Infect Dis       Date:  2019-08-09       Impact factor: 3.090

Review 3.  Seroprevalence of ToRCH Pathogens in Southeast Asia.

Authors:  Franziska E Fuchs; Maude Pauly; Antony P Black; Judith M Hübschen
Journal:  Microorganisms       Date:  2021-03-11

4.  Assessing herd immunity against rubella in Japan: a retrospective seroepidemiological analysis of age-dependent transmission dynamics.

Authors:  Ryo Kinoshita; Hiroshi Nishiura
Journal:  BMJ Open       Date:  2016-01-27       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.